Regulon

Regulon: R-1395

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
131.5936810Pr-108Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
2983 ENSG00000061918 GUCY1B3 Q02153
9891 ENSG00000074590 NUAK1 O60285
2782 ENSG00000078369 GNB1 A0A140VJJ8
610 ENSG00000099822 HCN2 Q9UL51
1917 ENSG00000101210 EEF1A2 Q05639
333 ENSG00000105290 APLP1 P51693
55700 ENSG00000116871 MAP7D1 Q3KQU3
6253 ENSG00000125744 RTN2 O75298
1173 ENSG00000161203 AP2M1 Q96CW1
55323 ENSG00000166173 LARP6 Q9BRS8
79605 ENSG00000177614 PGBD5 Q8N414
527 ENSG00000185883 ATP6V0C P27449
23396 ENSG00000186111 PIP5K1C O60331

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
CINACIGUATGUCY1B1Small moleculeACTIVATORSoluble guanylate cyclase activator20
SODIUM NITROPRUSSIDEGUCY1B1Small moleculeACTIVATORSoluble guanylate cyclase activator40
OLINCIGUATGUCY1B1Small moleculePOSITIVE ALLOSTERIC MODULATORSoluble guanylate cyclase positive allosteric modulator20
PENTAERYTHRITOL TETRANITRATEGUCY1B1Small moleculeACTIVATORSoluble guanylate cyclase activator40
VERICIGUATGUCY1B1Small moleculeACTIVATORSoluble guanylate cyclase activator40
RIOCIGUATGUCY1B1Small moleculePOSITIVE ALLOSTERIC MODULATORSoluble guanylate cyclase positive allosteric modulator40
NITROGLYCERINGUCY1B1Small moleculeACTIVATORSoluble guanylate cyclase activator40
NITRIC OXIDEGUCY1B1Small moleculeACTIVATORSoluble guanylate cyclase activator40
ATACIGUATGUCY1B1Small moleculeACTIVATORSoluble guanylate cyclase activator20
PLITIDEPSINEEF1A2Small moleculeINHIBITORElongation factor 1-alpha 2 inhibitor30
NITROPRUSSIDEGUCY1B1Small moleculeACTIVATORSoluble guanylate cyclase activator40
ISOSORBIDE MONONITRATEGUCY1B1Small moleculeACTIVATORSoluble guanylate cyclase activator40
RUNCACIGUATGUCY1B1Small moleculeACTIVATORSoluble guanylate cyclase activator20
PRALICIGUATGUCY1B1Small moleculeACTIVATORSoluble guanylate cyclase activator20
ISOSORBIDE DINITRATEGUCY1B1Small moleculeACTIVATORSoluble guanylate cyclase activator40

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1395

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs